Clinical Trial Update: Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports on doravirine concentrations and antiviral activity in cerebrospinal fluid of HIV-1 infected individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Doravirine (doravirine)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: HIV-1-infection | Phase 3 | Status: COMPLETED | Results posted: 2022-04-28